People with diabetes who experience the pain associated with nerve damage (diabetic peripheral neuropathy) have a new
treatment option--the first FDA-approved drug for managing the burning, tingling, and numbing sensations in the feet, legs,
or hands that mark this condition.
The drug, Cymbalta (duloxetine), was recently approved for treating the condition, the most common complication of diabetes.
In clinical trials, people treated with Cymbalta reported less pain compared to those given an inactive substance (placebo). Fifty-eight percent of people treated with Cymbalta reported at least a 30 percent sustained reduction of pain. In comparison, 34 percent of people treated with a placebo reported sustained pain reduction. The most commonly reported side effects were nausea, dry mouth, constipation, and diarrhea. In some cases, patients experienced dizziness and hot flashes.
Cymbalta is manufactured by Eli Lilly and Company of Indianapolis.
http://www.diabetesnews.com/
The drug, Cymbalta (duloxetine), was recently approved for treating the condition, the most common complication of diabetes.
In clinical trials, people treated with Cymbalta reported less pain compared to those given an inactive substance (placebo). Fifty-eight percent of people treated with Cymbalta reported at least a 30 percent sustained reduction of pain. In comparison, 34 percent of people treated with a placebo reported sustained pain reduction. The most commonly reported side effects were nausea, dry mouth, constipation, and diarrhea. In some cases, patients experienced dizziness and hot flashes.
Cymbalta is manufactured by Eli Lilly and Company of Indianapolis.
http://www.diabetesnews.com/
1 comment:
The Drug is the for good health whenever you are ill you have to take drug for the treatment of the illness and also use for new drug for neuropathic pain.
Post a Comment